scispace - formally typeset
B

Bent Nørgaard-Pedersen

Researcher at Statens Serum Institut

Publications -  202
Citations -  10477

Bent Nørgaard-Pedersen is an academic researcher from Statens Serum Institut. The author has contributed to research in topics: Amniotic fluid & Pregnancy. The author has an hindex of 48, co-authored 202 publications receiving 9764 citations. Previous affiliations of Bent Nørgaard-Pedersen include University of Copenhagen & Glostrup Hospital.

Papers
More filters
Journal ArticleDOI

Common variants conferring risk of schizophrenia

Hreinn Stefansson, +94 more
- 06 Aug 2009 - 
TL;DR: Findings implicating the MHC region are consistent with an immune component to schizophrenia risk, whereas the association with NRGN and TCF4 points to perturbation of pathways involved in brain development, memory and cognition.
Journal ArticleDOI

Elevated fetal steroidogenic activity in autism

TL;DR: These results provide the first direct evidence of elevated fetal steroidogenic activity in autism, and may be important as epigenetic fetal programming mechanisms and may interact with other important pathophysiological factors in autism.
Journal ArticleDOI

Neonatal Vitamin D Status and Risk of Schizophrenia: A Population-Based Case-Control Study

TL;DR: Both low and high concentrations of neonatal vitamin D are associated with increased risk of schizophrenia, and it is feasible that this exposure could contribute to a sizeable proportion of cases in Denmark.
Journal ArticleDOI

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

David M.S. McHugh, +245 more
- 01 Mar 2011 - 
TL;DR: An unprecedented level of cooperation and collaboration has allowed the objective definition of cutoff target ranges for 114 markers to be applied to newborn screening of rare metabolic disorders.

Neonatal Vitamin D Status and Risk of Schizophrenia

TL;DR: In this article, the association between neonatal vitamin D status and risk of schizophrenia was examined in an individual matched case-control study drawn from a population-based cohort, and the relationship was not explained by a wide range of potential confounding or interacting variables.